Your browser doesn't support javascript.
loading
Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial.
Madan, Jason J; Rosu, Laura; Tefera, Mamo Girma; van Rensburg, Craig; Evans, Denise; Langley, Ivor; Tomeny, Ewan M; Nunn, Andrew; Phillips, Patrick Pj; Rusen, I D; Squire, S Bertel.
Affiliation
  • Madan JJ; Warwick Medical School, University of Warwick, Coventry, England.
  • Rosu L; Centre for Applied Health Research and Delivery, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, England.
  • Tefera MG; Department of Business Management, Addis Ababa Science & Technology University, Addis Ababa, Ethiopia.
  • van Rensburg C; Health Economics and Epidemiology Research Office, University of Witwatersrand, Johannesburg, South Africa.
  • Evans D; Health Economics and Epidemiology Research Office, University of Witwatersrand, Johannesburg, South Africa.
  • Langley I; Centre for Applied Health Research and Delivery, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, England.
  • Tomeny EM; Centre for Applied Health Research and Delivery, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, England.
  • Nunn A; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, London, England.
  • Phillips PP; Department of Medicine, University of California San Francisco, San Francisco, United States of America (USA).
  • Rusen ID; Division of Research and Development, Vital Strategies, New York, USA.
  • Squire SB; Centre for Applied Health Research and Delivery, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, England.
Bull World Health Organ ; 98(5): 306-314, 2020 May 01.
Article in En | MEDLINE | ID: mdl-32514196

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 3_ND Database: MEDLINE Main subject: Health Care Costs / Cost of Illness / Tuberculosis, Multidrug-Resistant / Antitubercular Agents Type of study: Clinical_trials / Health_economic_evaluation Limits: Humans Country/Region as subject: Africa Language: En Journal: Bull World Health Organ Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 3_ND Database: MEDLINE Main subject: Health Care Costs / Cost of Illness / Tuberculosis, Multidrug-Resistant / Antitubercular Agents Type of study: Clinical_trials / Health_economic_evaluation Limits: Humans Country/Region as subject: Africa Language: En Journal: Bull World Health Organ Year: 2020 Document type: Article